The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study
暂无分享,去创建一个
A. Keech | M. Taskinen | P. Barter | A. Jenkins | A. Januszewski | W. Hung | A. Xu | K. Rye | K. Ong | D. Sullivan | R. O'Connell | R. Scott | Andrzej S. Januszewski